# 



## 

|||Page|
|---|---|---|
|Trustees'<br>Annual<br>Report|||
|Independent<br>Examiner's|Report||
|Statement of Financial<br>Activities for the year ended 31 March 2023|||
|Balance Sheet as at 31|March 2023||
|Cash Flow Statement|||
|Notes to the Financial Statements||10|
|Notes to the Cash Flow|Statement|13|





## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

|||||2022/23|2022/23|2022/23|2021/22|
|---|---|---|---|---|---|---|---|
||||Note|Unrestricted|Restricted|Total|Total|
|||||Funds<br>6|Funds<br>f|Funds<br>6|Funds<br>6|
|Income:||||||||
|Donations<br>and legacies|||2|15,326|12,960|28,286|21,719|
|Total income||||15,326|12,960|28,286|21,719|
|Expenditure:||||||||
|Expenditure<br>ofcharitable|activities|||||||
|Administration<br>expenses||||(11,772)|0|(11,772)|(11,360)|
|Grants to Ambassador|Theatre Group|||0|10210|10,210|4,846|
|Total expenditure||||11772|10,210|21,982|16,206|
|Net income / (expenditure)||and net||3,554|2,750|6,304|5,513|
|movement<br>in funds for|the|year||||||
|Reconciliation<br>offunds||||||||
|Total funds brought forward||||13,444|2,288|15,732|10,219|
|Tctal funds carried forward||||16998|5,038|22036|15732.|





## 

## 

|||Note|2022/23|2022/23|2021/22|2021/22|
|---|---|---|---|---|---|---|
|||||6|L'||
|Investments|||||||
|Investments||||||0|
|Current Assets|||||||
|Debtors|||0||8,588||
|Cash in hand|||22,036||7,521||
||||22,036||16,108||
|Current Liabilities|||||||
|Creditors<br>falling due within|one year|9|||(376)||
|Net Current Assets||||22,036||15,732|
|Total Assets less Current|Liabilities|||22,036||15,732|
|The Funds ofthe Charity:||10|||||
|Unrestricted<br>income funds||||16,998||13,444|
|Restricted<br>income funds||||5,038||2,288|
|Total Charity Funds||||22,036||15,732|



## 



## 

||||||Note|2022/23|2021/22|
|---|---|---|---|---|---|---|---|
|||||||6|5|
|Cash flows from operating||activities||||||
|Cash generated|by (used in) operations||||11|14516|3034|
|Net cash provided<br>by (used||in) operating|activities|||14516|3,034|
|Cash flows from investing||activities||||||
|Interest received||||||||
|Interest invested||||||||
|Net cash provided<br>by (used||in) investing|activities|||0|0|
|Change<br>in cash|and cash|equivalents||||14,516|(3,034)|
|Cash and cash|equivalents|at the beginning||ofyear|12|7,521|10555|
|Cash and cash|equivalents|at the end|ofyear||12|22,036|7521|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 


## 

## 

## 



## 

## 

## 

## 

## 

|DEBTORS|||||||||
|---|---|---|---|---|---|---|---|---|
|||||||2022/2023||2021/2022|
|||||||E||8|
|Accrued income||||||||8,558|
|CREDITORS: AMOUNTS|||FALLING|DUE WITHIN|ONE YEAR||||
|||||||2022/2023||2021/2022|
|||||||E||E|
|Accrued expenses||||||||376|
|MOVEMENT<br>IN FUNDS|||||||||
|||||Balance as||||Balance as|
|||||at|Income|Expenditure||at|
|||||31/03/2022<br>8|8|8||31/03/2023<br>f|
|Unrestricted|Funds||||||||
|General Reserve||||13,444|3,554||0|16,998|
|Restricted Funds|||||||||
|Dr Gilbert's|Fund|||2,288|||0|2,268|
|Community|Foundation|Grants|||2,750||0|2750|
|Total Funds||||15,732|6,304||0|22036|





## 

## 

||||||2022/23|2021/22|
|---|---|---|---|---|---|---|
||||||6|2|
|Net income/(expenditure)<br>for||the reporting||pedod|6,304|5,513|
|Adjustments<br>for:|||||||
|Deduct interest income shown||in investing|activities||0|0|
|(Increase)/decrease|in debtors||||8,588|(8,588)|
|Increase/(decrease)|in creditors||||(376)|40|
|Net cash provided|by (used in) operating|||activities|14,516|(3,034)|



|||||2022/23|2021/22|
|---|---|---|---|---|---|
|||||6|K|
|Cash|and|cash|equivalents|22036|7521|